Spindletop Health Acquisition Corp.
SHCAW
NASDAQ Global Market0.00
USD
+0.00
- -
CIK
0001848558
CUSIP
84854Q111
Return %
Stock
S&P500
1Y
- -
18.21
3Y
-99.87
63.29
5Y
-99.87
74.90
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Evan S. Melrose
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 7000 N. Mopac Expressway Austin TX United States of America 78731
- CIK
- 0001848558
- Similar Companies
- Business
- Spindletop Health Acquisition Corp is a blank check company formed in 2021 and headquartered in Austin, Texas, focused on effecting mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar business combinations primarily within the healthcare and healthcare-related industries in the United States. The company targets a broad spectrum of sectors including healthcare services, healthcare information technology, insurance and related products, biotechnology, pharmaceuticals, medical devices, and diagnostics. Spindletop Health Acquisition Corp does not have significant operations of its own but seeks to acquire and build healthcare businesses leveraging the extensive industry experience of its executive team and advisors. Recent major developments include its initial public offering aimed at raising $200 million to fund acquisitions, with a strategic emphasis on healthcare investments within the U.S. market. The company is led by CEO Evan Melrose and Chairman James Henry and plans to capitalize on strategic partnerships, acquisitions, and business expansions in the healthcare sector, although as of late 2022, the company announced plans for liquidation following a decision by its board not to extend its business combination period. This indicates a recent major operational change involving the winding up of its affairs and redemption of its public shares. The company operates through its acquisition strategy rather than direct product or service manufacturing or sales. Its business model revolves around identifying and combining with healthcare businesses to create value in healthcare services and technology domains.